Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...

Peregrin Sorter, a hearing examiner with Laminar Law, provided two written decisions on March 13 approving the 104-lot Bell ...

This article highlights and compares the various technology platforms available to provide technical insight into the ...

Sequim’s contracted hearing examiner has approved two developments totaling 128 residential lots in the southern part of city limits. Peregrin Sorter, a hearing examiner with Laminar Law, provided two ...

A: The wires are often labeled simply as phase 1, 2, and 3 or as L1, L2, and L3. Depending on the configuration, there may also be a neutral wire. Q: What is the power-path flow from source to load? A ...

George Town, Cayman Islands, March 18, 2025 (GLOBE NEWSWIRE) -- Flow, the leading platform for digital consumer experiences, gaming, and application development, is ushering in the next generation ...

The Academy agreed with Nora, awarding “Flow” the Oscar for Best Animated film, defeating Pixar’s “Inside Out 2” and Universal’s “The Wild Robot.” Not that it matters, but I agree ...

DENISON, Texas (KXII) - Denison is inspecting its water lines to make sure they are up to new EPA standards at no cost to residents. Phase one of the project began in the fall of 2024, when ...

Welspun Corp secures new orders worth Rs 2,400 crore for coated pipes in the US market, bolstering its order book to Rs 20,000 crore. The orders will be executed in FY26 and FY27. New Delhi, Mar 17 ...

PHILADELPHIA - The Eagles signed two tight ends in Phase II in free agency this week, which led to the natural speculation that Philadelphia is prepared to move on from veteran star Dallas Goedert ...

The compact FT-Me seats two, takes up just half a parking space, and is designed to offer plenty of flexibility in a small package. Stan Peters, who leads New Mobility Planning and Development at ...

The primary end point of 1-year overall survival (OS) rate has been met in the phase 2 TEDOPaM (GERCOR D17-01 PRODIGE 63 trial) trial of OSE2101 (Tedopi) for the treatment of patients with advanced or ...